腹腔镜Roux-en-Y胃旁路术后使用SGLT2抑制剂相关的正常血糖性糖尿病酮症酸中毒 - Suppr

Suppr

超能文献

Euglycemic Diabetic Ketoacidosis Associated With Use of SGLT2 Inhibitor After Laparoscopic Roux-en-Y Gastric Bypass.

作者信息

Yared Katherine E, Mancini Gregory J

机构信息

21823 Department of Surgery, University of Tennessee Graduate School of Medicine, Knoxville, TN, USA.

出版信息

Am Surg. 2021 Dec;87(12):1997-1999. doi: 10.1177/0003134820940286. Epub 2020 Aug 19.

DOI:10.1177/0003134820940286

PMID:32812784

Abstract

摘要

相似文献

Euglycemic Diabetic Ketoacidosis Associated With Use of SGLT2 Inhibitor After Laparoscopic Roux-en-Y Gastric Bypass.腹腔镜Roux-en-Y胃旁路术后使用SGLT2抑制剂相关的正常血糖性糖尿病酮症酸中毒

Am Surg. 2021 Dec;87(12):1997-1999. doi: 10.1177/0003134820940286. Epub 2020 Aug 19.

Euglycaemic diabetic ketoacidosis in bariatric surgery patients with type 2 diabetes taking canagliflozin.接受卡格列净治疗的2型糖尿病肥胖手术患者的正常血糖性糖尿病酮症酸中毒

BMJ Case Rep. 2018 Aug 20;2018:bcr-2017-221527. doi: 10.1136/bcr-2017-221527.

Immediate Euglycemic Diabetic Ketoacidosis After Gastric Bypass in a Patient with Type II Diabetes.II型糖尿病患者胃旁路术后即刻发生正常血糖性糖尿病酮症酸中毒

Obes Surg. 2021 Jun;31(6):2787-2790. doi: 10.1007/s11695-021-05263-7. Epub 2021 Feb 10.

[Diabetic euglycemic ketosis or ketoacidosis in individuals with type 2 diabetes treated by SGLT2 inhibitors: A series of Belgian clinical cases].[2型糖尿病患者使用SGLT2抑制剂治疗后出现的糖尿病正常血糖性酮症或酮症酸中毒：比利时系列临床病例]

Rev Med Interne. 2020 Apr;41(4):226-231. doi: 10.1016/j.revmed.2019.12.006. Epub 2019 Dec 19.

Two cases of euglycemic diabetic ketoacidosis after bariatric surgery associated with sodium-glucose cotransporter-2 inhibitor use.两例减肥手术后出现正常血糖性糖尿病酮症酸中毒的病例，与使用钠-葡萄糖协同转运蛋白2抑制剂有关。

Obes Surg. 2021 Aug;31(8):3848-3850. doi: 10.1007/s11695-021-05391-0. Epub 2021 Apr 24.

Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial.腹腔镜袖状胃切除术与腹腔镜Roux-en-Y胃旁路术对病态肥胖患者体重减轻的影响：SM-BOSS随机临床试验

JAMA. 2018 Jan 16;319(3):255-265. doi: 10.1001/jama.2017.20897.

SGLT2 Inhibitors and Euglycemic Ketoacidosis.钠-葡萄糖协同转运蛋白2抑制剂与正常血糖性酮症酸中毒

Am J Ther. 2018 Jul/Aug;25(4):e498-e500. doi: 10.1097/MJT.0000000000000587.

Euglycemic Diabetic Ketoacidosis Associated With SGLT2 Inhibitor Therapy: A Case Report.与 SGLT2 抑制剂治疗相关的血糖正常的糖尿病酮症酸中毒：病例报告。

AACN Adv Crit Care. 2023 Mar 15;34(1):27-32. doi: 10.4037/aacnacc2023830.

Euglycemic Ketoacidosis With Sodium-Glucose Cotransporter-2 Inhibitor.钠-葡萄糖协同转运蛋白2抑制剂所致正常血糖性酮症酸中毒

Am J Ther. 2018 Sep/Oct;25(5):e590-e591. doi: 10.1097/MJT.0000000000000602.

Treatment of a Severe Form of Euglycemic Ketoacidosis in a Patient Treated with SGLT-2 Inhibitors with the Aid of Somatostatin.应用生长抑素治疗 SGLT-2 抑制剂治疗患者的严重非酮症高血糖性酸中毒

G Ital Nefrol. 2023 Aug 31;40(4):2023-vol4.

引用本文的文献

Postoperative Outcomes Among Sodium-Glucose Cotransporter 2 Inhibitor Users.钠-葡萄糖协同转运蛋白2抑制剂使用者的术后结局

JAMA Surg. 2025 Apr 30. doi: 10.1001/jamasurg.2025.0940.

Sodium-glucose cotransporter 2 inhibitor-associated perioperative ketoacidosis: a systematic review of case reports.钠-葡萄糖共转运蛋白 2 抑制剂相关围手术期酮症酸中毒：病例报告的系统评价。

J Anesth. 2023 Jun;37(3):465-473. doi: 10.1007/s00540-023-03174-8. Epub 2023 Feb 27.

New Diabetic Medication Sodium-Glucose Cotransporter-2 Inhibitors Can Induce Euglycemic Ketoacidosis and Mimic Surgical Diseases: A Case Report and Review of Literature.新型糖尿病药物钠-葡萄糖协同转运蛋白2抑制剂可诱发正常血糖性酮症酸中毒并酷似外科疾病：一例报告及文献复习

Front Surg. 2022 Mar 24;9:828649. doi: 10.3389/fsurg.2022.828649. eCollection 2022.

SGLT-2 inhibitors associated euglycemic and hyperglycemic DKA in a multicentric cohort.在一个多中心队列中，SGLT-2 抑制剂与血糖正常和高血糖性 DKA 相关。

Sci Rep. 2021 May 13;11(1):10293. doi: 10.1038/s41598-021-89752-w.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验